Design
Review
Authors
Loading...
IMT supports atherosclerosis research as a surrogate endpoint; leaves open routine clinical use without stronger prospective validation.
Key points are not available for this paper at this time.
Joseph F. Polak (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: